Technical Description
The present invention relates to a non-invasive assay and a method for early detection or preliminary screening of ovarian cancer. This method involves a biomarker panel comprising of HOXA9 and HIC1 genes in biological sample from ovarian cancer patients using methylated DNA based multiplex q-PCR assay with increased sensitivity and specificity at an early stage.
Problems Addressed
- Delayed Disease Detection
- Non-specificity
- Low Sensitivity
- Inaccurate
- Expensive
- Limitations of Existing Methods
Tech Features
- Non-Invasive Assay
- High Sensitivity
- High Specificity
- Less Complex Method
- Inexpensive
- Accuracy
- Early Detection
Target Audience
- Healthcare & Medical Sector
- Diagnostic Industry
- Biomedical Sectors
- Research & Development
Tech ID: P14-1660 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
